Rentokil Initial Plc /Fi (RKLIF) Cash & Equivalents (2019 - 2026)

Rentokil Initial (RKLIF) has reported Cash & Equivalents for 8 consecutive years, with $2.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 46.3% year-over-year to $2.5 billion in Q2 2026; TTM through Jun 2026 was $2.5 billion, a 46.3% increase from a year earlier, with the FY2025 full-year figure at $2.3 billion, up 100.26% from the prior year.
• Cash & Equivalents was $2.5 billion for Q2 2026 at Rentokil Initial, up from $2.3 billion in the prior quarter.
• Over five years, Cash & Equivalents peaked at $2.5 billion in Q4 2022 and troughed at $6.0 million in Q3 2025.
• A 5-year average of $1.6 billion and a median of $1.9 billion in 2023 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents surged 384.82% in 2023 and plunged 38.76% in 2024, its largest moves.
• Over 5 years, Cash & Equivalents stood at $2.5 billion in 2022, then dropped by 23.83% to $1.9 billion in 2023, then sank by 38.76% to $1.2 billion in 2024, then soared by 95.33% to $2.3 billion in 2025, then advanced by 6.55% to $2.5 billion in 2026.
• The last three Cash & Equivalents figures came in at $2.5 billion (Q2 2026), $2.3 billion (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.